Daniel K. Spiegelman, Director at MYRIAD GENETICS INC (MYGN), sold 17,276 shares at $23.01 ($398K) on 2023-06-02, disclosed to the SEC on 2023-06-02.
Open-market sale of $398k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.01 | 8,638 | $199K | 50.0% |
| 2 | $23.01 | 8,638 | $199K | 50.0% |
| Total | $23.01 avg | 17,276 | $398K | 100% |
| Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |
| BMRN | SELL | 2019-04-03 | $1.2M | — | Filing → |